Study guide

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria

Key Takeaways Explain This Topic AI

The Microbiology TOS has 10 organ-system areas; respiratory, gastrointestinal and multisystemic infections (sepsis and HIV) carry 15% each.

Catalase separates staphylococci (positive) from streptococci and enterococci (negative); coagulase separates Staphylococcus aureus from coagulase-negative staphylococci.

MRSA resistance comes from the mecA gene on SCCmec, which encodes PBP2a with low beta-lactam affinity; VRE replaces D-Ala-D-Ala with D-Ala-D-Lac.

Lipid A of Gram-negative lipopolysaccharide is endotoxin; it activates TLR4 and drives septic shock, fever and DIC.

Cholera toxin and ETEC heat-labile toxin raise cAMP, diphtheria toxin and Pseudomonas exotoxin A ADP-ribosylate EF-2, and Shiga toxin cleaves 28S rRNA.

Last updated: October 2026

Why this area matters

The Board of Medicine TOS for Microbiology and Parasitology has 100 items in 10 content areas, each defined by an organ system:

Content area Topics named in the TOS Weight

Respiratory system Tonsillitis, sinusitis, mastoiditis; community-acquired and severe pneumonia, bronchopneumonia, bronchitis; pulmonary TB; emphysema, bronchiectasis 15%

Cardiovascular system Carditis, endocarditis, pericarditis, thrombophlebitis, rheumatic heart disease 10%

Gastrointestinal system Enterocolitis, gastroenteritis, hepatitis, typhoid and salmonellosis, shigellosis, cholera; ascariasis, hookworm, tapeworm, pinworm, amebic dysentery 15%

Nervous system Meningitis, encephalitis, PSP (red tide), spinal cord infections, rabies and other viral diseases 7%

Genitourinary system UTI, pyelonephritis, cystitis, urethritis, balanoposthitis, PID, genital ulcers 8%

Reproductive tract Genital and neonatal herpes, syphilis, HPV, molluscum contagiosum, CMV, HIV, cervicitis, prostatitis, orchitis 10%

Hematopoietic, lymphatic and immunologic Hemorrhagic fever, malaria, lymphogranuloma venereum, Epstein-Barr virus 7%

Integumentary system Viral rashes (measles, mumps, rubella, chickenpox, smallpox, fifth disease), fungal skin infections, tick-borne diseases 8%

  • Musculoskeletal system Osteomyelitis, arthritis, myositis, cellulitis 5%
  • Multisystemic infection Septicemia, septicopyemia, HIV/AIDS 15%

The competencies attached to every area are the same. You must be able to:

  • classify the agent;
  • describe its burden and distribution in the Philippines;
  • explain its pathogenesis and clinical picture;
  • choose diagnostic tests;
  • correlate drugs with organisms;

apply prevention, including immunization.

Questions therefore start from a patient: a farmer with fever and calf pain after a flood, a child with a barking cough, a woman with frothy discharge. You must work backward from the syndrome to the organism, its virulence factor, the laboratory test that confirms it and the drug or program that controls it. This section reviews the organism groups that recur across every organ system. The sections that follow apply them system by system, with Philippine programs and guidelines.

Specimens, stains and identification

Specimens: collect before antibiotics whenever possible, from the site of infection, in the right container.

Blood cultures: two or more sets from separate sites.

Sputum: a good specimen has many neutrophils and few squamous epithelial cells.

Urine: clean-catch midstream.

CSF: processed at once.

Stool for ova and parasites: fresh.

Direct examination:

The Gram stain classifies most bacteria.

The Ziehl-Neelsen or Kinyoun acid-fast stain detects mycobacteria. The modified acid-fast stain detects Nocardia and Cryptosporidium .

India ink shows the Cryptococcus capsule, and KOH mounts show fungal elements.

Giemsa stains malaria parasites, and darkfield microscopy shows spirochetes.

Culture media:

  • blood agar shows hemolysis;
  • chocolate agar supports Haemophilus and Neisseria ;
  • Thayer-Martin is selective for pathogenic Neisseria ;
  • MacConkey shows lactose fermentation;
  • TCBS grows Vibrio ;
  • Lowenstein-Jensen grows mycobacteria;
  • Sabouraud agar grows fungi;

Loeffler serum and tellurite media grow C. diphtheriae .

Non-culture tests:

  • antigen detection , for example dengue NS1, malaria HRP-2 and pneumococcal urinary antigen;
  • serology , which needs IgM or a fourfold rise in IgG;

nucleic acid amplification , for example Xpert MTB/RIF and HIV viral load.

Bacterial Cell Wall Architecture & Gram Staining Principles

The Gram stain divides eubacteria into two primary categories based on cell wall composition:

Gram-Positive Envelope: Composed of a thick, multi-layered peptidoglycan meshwork (murein) cross-linked by transpeptidases (penicillin-binding proteins, PBPs). It incorporates teichoic acid and lipoteichoic acid, which mediate adherence to mucosal surfaces and induce cytokine release (interleukin-1, tumor necrosis factor-alpha) resembling endotoxemia. The thick peptidoglycan layer traps the crystal violet-iodine complex during acetone-alcohol decolorization, staining the organism purple or deep blue.

Gram-Negative Envelope: Possesses a thin, single-layered peptidoglycan layer enclosed within a complex outer membrane. The space between the inner and outer membranes is the periplasmic space , housing beta-lactamases, transport proteins, and oligosaccharides. The outer membrane's outer leaflet is dominated by lipopolysaccharide (LPS) , composed of O-antigen polysaccharide, a conserved core polysaccharide, and Lipid A (the toxic endotoxin moiety responsible for septic shock, activating Toll-like receptor 4 [TLR4], complement cascade, and tissue factor). Acetone-alcohol decolorizes the thin wall, which subsequently takes up the counterstain safranin, staining red or pink.

Clinically Significant Gram-Positive Cocci

Gram-positive cocci are classified initially by the catalase test ( 2 H 2 O 2 → 2 H 2 O + O 2 2\text{H}_2\text{O}_2 \rightarrow 2\text{H}_2\text{O} + \text{O}_2 2 H 2 ​ O 2 ​ → 2 H 2 ​ O + O 2 ​ ), differentiating catalase-positive Staphylococcus from catalase-negative Streptococcus and Enterococcus .

Organism Key Diagnostic Discriminators Major Virulence Factors Primary Clinical Manifestations

Staphylococcus aureus Catalase (+), Coagulase (+), beta-hemolytic, golden-yellow pigment on mannitol salt agar (ferments mannitol) Protein A (binds Fc portion of IgG, inhibiting opsonization and phagocytosis); TSST-1 (superantigen activating massive T-cell cytokine storm); Enterotoxin (heat-stable, preformed food poisoning); Exfoliatin (cleaves desmoglein-1 in scalded skin syndrome); Panton-Valentine leukocidin (PVL) Skin and soft tissue infections (abscess, furuncle, carbuncle), acute infective endocarditis (tricuspid in IV drug users), osteomyelitis, septic arthritis, toxic shock syndrome, staphylococcal scalded skin syndrome (SSSS)

Staphylococcus epidermidis Catalase (+), Coagulase (-), Novobiocin sensitive Biofilm production (polysaccharide intercellular adhesin) Prosthetic valve endocarditis, ventricular shunt infections, prosthetic joint infections, central venous catheter bacteremia

Staphylococcus saprophyticus Catalase (+), Coagulase (-), Novobiocin resistant Surface hemagglutinin, urease Community-acquired urinary tract infections in sexually active young women (second to E. coli )

Streptococcus pneumoniae Catalase (-), alpha-hemolytic (green hue), lancet-shaped diplococci, Optochin sensitive , bile soluble (lysed by deoxycholate) Polysaccharide capsule (antiphagocytic, major virulence factor; quellung reaction positive); IgA protease; Pneumolysin Community-acquired lobar pneumonia ("rusty" sputum), otitis media, sinusitis, acute adult bacterial meningitis

Streptococcus pyogenes (Group A Strep) Catalase (-), beta-hemolytic, Bacitracin sensitive , Pyrrolidonyl arylamidase (PYR) positive M protein (antiphagocytic, molecular mimicry in rheumatic carditis); Streptolysin O (oxygen-labile, immunogenic ASO titer); Streptococcal pyrogenic exotoxin (SpeA/C superantigens in scarlet fever and toxic shock-like syndrome) Streptococcal pharyngitis, impetigo, erysipelas, cellulitis, necrotizing fasciitis, scarlet fever (strawberry tongue, sandpapery rash); Non-suppurative post-infectious sequelae: Acute Rheumatic Fever (follows pharyngitis only) and Post-Streptococcal Glomerulonephritis (follows pharyngitis or impetigo)

Streptococcus agalactiae (Group B Strep) Catalase (-), beta-hemolytic, Bacitracin resistant , CAMP test positive (enhances S. aureus beta-lysin hemolysis in arrow shape), Hippurate hydrolysis positive Polysaccharide capsule containing sialic acid Neonatal sepsis, pneumonia, and meningitis (screened with a vaginal-rectal swab at 36 to 37 weeks of gestation; intrapartum penicillin or ampicillin prophylaxis for carriers)

Enterococcus faecalis & E. faecium Catalase (-), gamma or variable hemolysis, grows in 6.5% NaCl and 40% bile (Bile Esculin positive) , PYR positive Intrinsic resistance to cephalosporins, biofilm formation Nosocomial urinary tract infections, biliary tract sepsis, subacute bacterial endocarditis; E. faecium exhibits high rates of vancomycin resistance

Molecular Basis of MRSA and VRE Resistance

Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance to all beta-lactams (penicillins, cephalosporins [except ceftaroline], carbapenems) is mediated by the chromosomal mecA gene located on the staphylococcal cassette chromosome mec (SCCmec). This gene encodes PBP2a , an altered transpeptidase with exceedingly low binding affinity for beta-lactams. Vancomycin is the drug of choice for invasive MRSA infections.

Vancomycin-Resistant Enterococcus (VRE): Mediated by plasmid- or transposon-borne vanA or vanB gene clusters that substitute the terminal cell wall dipeptide target D-alanyl-D-alanine (D-Ala-D-Ala) with D-alanyl-D-lactate (D-Ala-D-Lac) , reducing vancomycin binding affinity by more than 1,000-fold. Linezolid, daptomycin, and tigecycline are primary therapeutic alternatives.

Clinically Significant Gram-Positive Bacilli

Gram-positive bacilli are categorized into endospore-forming and non-spore-forming genera:

Spore-Forming Gram-Positive Bacilli

Bacillus anthracis : Aerobic spore former. Features a unique antiphagocytic poly-D-glutamate polypeptide capsule (not polysaccharide). Produces anthrax toxin consisting of three components: Protective Antigen (PA, mediates host entry), Lethal Factor (LF, a zinc-metalloprotease cleaving MAP kinase kinase, triggering necrosis and hypoxia), and Edema Factor (EF, a calmodulin-dependent adenylate cyclase that elevates intracellular cAMP). Manifests as cutaneous anthrax (painless black eschar surrounded by non-pitting gelatinous edema) or inhalational anthrax ("woolsorter's disease", hemorrhagic mediastinitis, widened mediastinum on chest radiograph).

Bacillus cereus : Aerobic spore former. Causes food poisoning via two distinct toxins: the emetic syndrome (caused by cereulide, a preformed heat-stable enterotoxin associated with reheated fried rice, incubation 1-6 hours) and the diarrheal syndrome (caused by a heat-labile enterotoxin produced in vivo associated with contaminated meats and vegetables, incubation 8-16 hours).

Clostridium tetani : Anaerobic spore former (tennis racket/drumstick appearance). Spores in soil enter wounds. Produces tetanospasmin , an A-B neurotoxin that travels via retrograde axonal transport to inhibitory Renshaw interneurons in the spinal cord. Its zinc-metalloprotease cleaves synaptobrevin (VAMP) , a SNARE protein, preventing release of inhibitory neurotransmitters GABA and glycine . This disinhibits lower motor neurons, causing severe spastic paralysis, trismus (lockjaw), risus sardonicus (sardonic smile), and opisthotonos (hyperextended arching of the spine).

Clostridium botulinum : Anaerobic spore former. Produces botulinum neurotoxin , which cleaves SNARE proteins (SNAP-25, synaptobrevin) in presynaptic peripheral cholinergic nerve terminals, preventing acetylcholine (ACh) release at neuromuscular junctions. This results in symmetric, descending flaccid paralysis , diplopia, dysarthria, dysphagia, and respiratory arrest. Infant botulism occurs from ingesting spores in unpasteurized honey, manifesting as constipation and hypotonia ("floppy baby syndrome").

Clostridioides difficile : Anaerobic spore former. Proliferates following broad-spectrum antibiotic therapy (clindamycin, cephalosporins, fluoroquinolones). Produces Toxin A (enterotoxin) , which damages brush-border enterocytes and incites inflammation, and Toxin B (cytotoxin) , which depolymerizes actin filaments, causing mucosal necrosis and pseudomembrane formation ( pseudomembranous colitis ). Diagnosis is made by stool nucleic acid amplification or toxin enzyme immunoassay. Treatment involves oral vancomycin or oral fidaxomicin.

Clostridium perfringens : Anaerobic spore former. Produces alpha-toxin (lecithinase / phospholipase C) , which hydrolyzes cellular phospholipids, causing massive hemolysis, vascular destruction, and tissue necrosis ( gas gangrene / clostridial myonecrosis with crepitus).

Non-Spore-Forming Gram-Positive Bacilli

Corynebacterium diphtheriae : Club-shaped pleomorphic Gram-positive rod in Chinese-character or palisade formations. Produces diphtheria toxin , an A-B exotoxin whose catalytic A domain catalyzes the ADP-ribosylation of elongation factor 2 (EF-2) , terminating host protein synthesis. Causes pharyngitis with an adherent, thick, gray-white pseudomembrane on the tonsils and posterior pharynx; attempts to dislodge it cause bleeding. Systemic toxin absorption causes myocarditis, cardiac arrhythmias, and motor neuropathies (recurrent laryngeal nerve palsy). Cultured on Loeffler coagulated serum slant and potassium tellurite agar (black/gray colonies); toxigenicity is confirmed via the Elek immunodiffusion test .

Listeria monocytogenes : Facultative intracellular Gram-positive rod. Exhibits distinctive tumbling motility at room temperature (20-25°C) and cold enrichment growth at 4°C. Spreads from cell to cell by polymerizing host actin into "actin rockets" mediated by the ActA protein. Transmitted via unpasteurized milk, soft cheeses, and contaminated deli meats. In neonates and elderly or immunocompromised hosts, it causes life-threatening meningitis and sepsis. Listerial meningitis requires ampicillin (which possesses activity against Listeria , unlike cephalosporins, to which Listeria exhibits intrinsic resistance).

Clinically Significant Gram-Negative Cocci

The genus Neisseria comprises Gram-negative diplococci that are oxidase-positive and grow on enriched chocolate agar or selective Thayer-Martin medium (containing vancomycin, colistin, nystatin, and trimethoprim to inhibit Gram-positives, Gram-negative bacilli, fungi, and Proteus swarming).

  • Characteristic Neisseria meningitidis (Meningococcus) Neisseria gonorrhoeae (Gonococcus)
  • Polysaccharide Capsule Present (antiphagocytic, basis of serogroups A, B, C, Y, W-135) Absent
  • Carbohydrate Fermentation Ferments Maltose and Glucose Ferments Glucose only (Maltose negative)

Primary Portal of Entry Nasopharynx (colonization via pili, entry into bloodstream) Genital tract mucous membranes, anorectum, pharynx

Clinical Manifestations Meningococcemia, purpuric/petechial rash, acute bacterial meningitis, Waterhouse-Friderichsen syndrome (bilateral adrenal hemorrhage, fulminant septic shock, DIC) Urethritis (purulent urethral discharge), cervicitis, Pelvic Inflammatory Disease (PID), Fitz-Hugh-Curtis syndrome ("violin-string" adhesions between liver capsule and parietal peritoneum), septic arthritis, ophthalmia neonatorum

Antigenic Variation Capsule is stable; pili exhibit phase variation Extensive antigenic variation of pili and Opa proteins; no lasting immunity

Prevention & Chemoprophylaxis Polysaccharide conjugate vaccine; chemoprophylaxis for close contacts with Rifampicin , Ceftriaxone , or Ciprofloxacin Ceftriaxone IM (single dose), plus doxycycline if chlamydia has not been excluded; neonatal ocular prophylaxis

Gram-Negative Bacilli: Enteric & Non-Enteric Pathogens

Gram-negative bacilli are initially differentiated by their ability to ferment lactose on MacConkey agar (pink colonies = fermenters; colorless colonies = non-fermenters):

Lactose Fermenters (Pink on MacConkey Agar)

Escherichia coli : Indole-positive, metallic green sheen on Eosin Methylene Blue (EMB) agar.

Enterotoxigenic E. coli (ETEC): Produces Heat-Labile toxin (LT) , which activates adenylate cyclase ( c A M P ↑ cAMP \uparrow c A MP ↑ ), and Heat-Stable toxin (ST) , which activates guanylate cyclase ( c G M P ↑ cGMP \uparrow c GMP ↑ ). Causes watery traveler's diarrhea .

Enterohemorrhagic E. coli (EHEC / STEC, prototype O157:H7): Does not ferment sorbitol on sorbitol-MacConkey agar (SMAC). Produces Shiga-like toxins (Stx1 and Stx2) , which inactivate the 60S ribosomal subunit by cleaving 28S rRNA. Causes hemorrhagic colitis and Hemolytic Uremic Syndrome (HUS) : a clinical triad of microangiopathic hemolytic anemia (schistocytes on blood smear), thrombocytopenia, and acute kidney injury. Antibiotic therapy is contraindicated in STEC infections , as it triggers bacteriophage induction and increases toxin release, accelerating HUS progression.

Uropathogenic E. coli (UPEC): Possesses P-fimbriae (pyelonephritis-associated pili) that bind galactose receptors on uroepithelial cells; accounts for > 80% of uncomplicated community-acquired UTIs.

Klebsiella pneumoniae : Non-motile, prominent polysaccharide mucoid capsule. Ferments lactose vigorously. Causes community-acquired lobar pneumonia in alcoholics and diabetics, characteristically producing thick, bloody, "currant jelly" sputum with upper lobe cavitary necrosis.

Non-Lactose Fermenters (Colorless on MacConkey Agar)

Salmonella enterica serovar Typhi: Oxidase negative, produces H 2 S \text{H}_2\text{S} H 2 ​ S (black colonies on Hektoen enteric agar), motile. Transmitted via contaminated water and food. Penetrates intestinal M-cells of Peyer patches and disseminates inside macrophages. Manifests as typhoid (enteric) fever : step-ladder fever, relative bradycardia ( Faget sign ), abdominal pain, hepatosplenomegaly, faint erythematous "rose spots" on the trunk, and leukopenia. Asymptomatic carrier state is maintained by chronic colonization in the gallbladder . First-line treatment includes ceftriaxone or ciprofloxacin.

Shigella dysenteriae & S. flexneri : Oxidase negative, non-motile, does NOT produce H 2 S \text{H}_2\text{S} H 2 ​ S . Exhibits an exceedingly low infectious inoculum (as few as 10-100 organisms cause disease). Invades intestinal M-cells and escapes the phagosome to polymerize actin for intra- and intercellular motility. Causes bacillary dysentery : fever, severe tenesmus, and frequent small-volume bloody, mucoid stools.

Pseudomonas aeruginosa : Obligate aerobe, oxidase-positive, non-lactose fermenter. Produces the blue-green pigments pyocyanin and pyoverdine , and cultures have a characteristic sweet, grape-like odor . Possesses Exotoxin A , which inhibits host protein synthesis through ADP-ribosylation of EF-2 (identical mechanism to diphtheria toxin). Important opportunistic pathogen causing ventilator-associated pneumonia, ecthyma gangrenosum (black necrotic skin bullae in neutropenic patients), hot tub folliculitis, malignant otitis externa in diabetics, and corneal ulcers in contact lens wearers.

Vibrio cholerae : Comma-shaped, oxidase-positive, grows on TCBS (thiosulfate-citrate-bile salts-sucrose) agar as yellow colonies. Thrives in brackish coastal waters and contaminated water supplies. Produces cholera toxin , an A-B enterotoxin whose A subunit ADP-ribosylates the G α s G_{\alpha s} G α s ​ regulatory protein, maintaining adenylate cyclase in a continuously active state ( c A M P ↑ cAMP \uparrow c A MP ↑ ). This leads to active secretion of chloride and bicarbonate ions into the intestinal lumen, causing massive, painless, watery "rice-water" diarrhea that can exceed 1 liter/hour, precipitating lethal hypovolemic shock. Primary therapy is aggressive fluid and electrolyte replacement using Oral Rehydration Salts (ORS) or IV Ringer's lactate; doxycycline shortens shedding.

Campylobacter jejuni : Curved, comma- or gull-wing-shaped Gram-negative rod, oxidase-positive, microaerophilic, grows at 42°C on Campy-BAP agar. Transmitted by undercooked poultry and unpasteurized milk. Causes inflammatory, bloody diarrhea and serves as the leading antecedent infectious trigger for Guillain-Barré syndrome (via molecular mimicry between lipooligosaccharides and human peripheral nerve gangliosides GM1) and reactive arthritis.

Helicobacter pylori : Curved, flagellated Gram-negative rod. Produces abundant urease , which hydrolyzes gastric urea into ammonia and carbon dioxide, neutralizing local gastric acidity. Causes chronic active gastritis, duodenal and gastric peptic ulcers, and elevates the risk for gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma .

Haemophilus influenzae : Pleomorphic Gram-negative coccobacillus. Fastidious organism requiring Factor X (hemin) and Factor V (NAD) for growth on chocolate agar. Exhibits the satellite phenomenon , growing as tiny colonies around Staphylococcus aureus streaks on sheep blood agar (because S. aureus lyses RBCs to liberate Factor X and actively secretes Factor V). Encapsulated type b (Hib) strains cause acute epiglottitis ("thumbprint sign" on lateral neck radiograph), pediatric meningitis, and septic arthritis.

Exotoxins and endotoxin at a glance

  • Toxin Mechanism Result
  • Cholera toxin, ETEC heat-labile toxin ADP-ribosylate Gs, so cAMP rises Secretory watery diarrhea

Diphtheria toxin, Pseudomonas exotoxin A ADP-ribosylate EF-2 Stops protein synthesis; myocarditis, tissue necrosis

  • Pertussis toxin ADP-ribosylates Gi Lymphocytosis, paroxysmal cough
  • Shiga and Shiga-like toxins Cleave 28S rRNA of the 60S subunit Dysentery, hemolytic uremic syndrome
  • Tetanospasmin Cleaves synaptobrevin in inhibitory interneurons Spastic paralysis
  • Botulinum toxin Cleaves SNARE proteins at cholinergic terminals Descending flaccid paralysis
  • TSST-1, streptococcal pyrogenic exotoxins Superantigens bridge MHC II and T-cell receptor Toxic shock
  • Lipid A (endotoxin) Activates TLR4, complement and tissue factor Fever, septic shock, DIC

Viruses are classified by nucleic acid and envelope. Fungi are classified as yeasts, molds or dimorphic fungi. Their individual diseases are covered with the organ systems they affect.